In a report released yesterday, Eric Serotta from Morgan Stanley initiated coverage with a Buy rating on Philip Morris (PM – Research Report) ...
and oral nicotine products primarily under the IQOS and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness and healthcare products. Philip Morris ...
Barclays analyst Gaurav Jain maintained a Buy rating on Philip Morris (PM – Research Report) today and set a price target of $145.00. The ...
FDA authorizes the marketing of 20 Zyn products because they pose fewer health risks than cigarettes and most smokeless products Shares of Philip Morris International ... Below is the list of ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Shares of Philip Morris International Inc. extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine ...